Abbott India vs Sanofi India: share price, P/E, ROE and financials compared
Abbott India
Sanofi India
Abbott India and Sanofi India at a glance
Abbott India and Sanofi India are both listed in Healthcare. Abbott India is the larger by market cap, at ₹55,981 Cr against ₹7,561 Cr for Sanofi India (7.4 times as large). On valuation, Sanofi India has the lower P/E (20.7× against 34.7×) and the lower price-to-book (9.15× against 11.73×). On returns and margins, Sanofi India has the higher ROCE (58.5% against 41.9%) and the higher ROE (44.1% against 34.5%). Over three years, Abbott India has faster 3-year sales growth (+9.0% against −12.6% a year) and faster 3-year profit growth (+17.8% against −19.3% a year). Neither carries much debt for its equity: debt-to-equity is 0.04× for Abbott India and 0.02× for Sanofi India.
Key metrics, side by side
| Metric | Abbott IndiaABBOTINDIA | Sanofi IndiaSANOFI |
|---|---|---|
| Price (₹) | 26,345.00 | 3,283.10 |
| Market cap (₹ Cr) | 55,981 | 7,561 |
| P/E | 34.7× | 20.7× (the lower figure, shaded) |
| P/B | 11.73× | 9.15× (the lower figure, shaded) |
| Dividend yield, trailing | 2.49% | 6.03% (the higher figure, shaded) |
| ROE | 34.5% | 44.1% (the higher figure, shaded) |
| ROCE | 41.9% | 58.5% (the higher figure, shaded) |
| Operating margin (OPM) | 28.1% | 28.0% |
| Net margin (NPM) | 23.1% (the higher figure, shaded) | 20.0% |
| Sales CAGR 3Y | +9.0% (the higher figure, shaded) | −12.6% |
| Profit CAGR 3Y | +17.8% (the higher figure, shaded) | −19.3% |
| Debt to equity | 0.04× | 0.02× |
| Interest cover | 84.2× | – |
| Net profit TTM (₹ Cr) | 1,615 | 365 |
| 1Y return | −9.4% (the higher figure, shaded) | −28.9% |
| Promoter holding | 74.99% | 60.40% |
Abbott India vs Sanofi India: common questions
Which is bigger, Abbott India or Sanofi India?
By market cap, Abbott India is bigger at ₹55,981 Cr, against ₹7,561 Cr for Sanofi India (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹1,615 Cr for Abbott India and ₹365 Cr for Sanofi India.
Which has a lower P/E ratio, Abbott India or Sanofi India?
Abbott India trades at a P/E of 34.7× and Sanofi India at 20.7×. Sanofi India has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Abbott India or Sanofi India?
Abbott India reports a return on equity of 34.5% and Sanofi India 44.1%. Sanofi India has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Abbott India or Sanofi India?
Over the last three years: Sales grew +9.0% a year at Abbott India and −12.6% at Sanofi India, so Abbott India grew sales faster; profit grew +17.8% a year at Abbott India and −19.3% at Sanofi India, so Abbott India grew profit faster. Past growth doesn’t predict future growth.